Mitsubishi UFJ Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$8.63K Hold
2024
Q1
$8.92K Hold
2023
Q4
$8.88K Hold
2023
Q3
$4.61K Buy